Faster start-up • Scientific coordination • European model access
InVivoBridge provides access to preclinical in vivo models through a
coordinated network of certified CRO and academic partners across Germany
and the Netherlands.
Our infection and immunology-focused portfolio supports vaccine, biologic,
antibody, and immunotherapy development ensuring data reliability and
regulatory compliance.
We connect biotech innovators with validated infection and immunology
models that accelerate preclinical decisions.
Each model is backed by certified partners and managed through
coordinated scientific oversight ensuring consistency and reproducibility
across studies.
formats tailored to your study needs.
Dose optimization, tolerability, exposure analysis.
Realistic bacterial and viral infection simulations.
Vaccine and therapeutic performance assessment.
In vivo fluorescence / bioluminescence imaging.
Early-stage data for rapid go/no-go decisions.
1. Pathogen load (CFU / TCID50)
2. Survival and disease scoring
3. Lung pathology / histology
4. Flow cytometry immune profiling
5. Cytokine analysis
6. Antibody titres / neutralization
All studies coordinated through InVivoBridge adhere strictly to international
ethical and regulatory standards, ensuring animal welfare and scientific
integrity.
EU Directive 2010/63
Paragraph 44 (Germany – IfSG)
Article 9 (Netherlands – Dierproevenwet)
FELASA B Animal Handling Certification
Let’s align science, strategy, and execution to accelerate your next in vivo program efficiently and compliantly across Europe.
Study Coordination
Regulatory Support
CRO + Academic Collaboration
Integrated Reporting
Immunology Model Access